Thursday, June 11

Browsing: Mipletamig

Diagnosis

Mipletamig Regimen Yields Clinical Benefit in Frontline AML Trial

By NewsCancerMay 6, 20260

Combining mipletamig with venetoclax (Venclexta) and azacitidine (Vidaza) produced clinical benefits and remissions in most patients with frontline acute myeloid…

Survivors

Mipletamig Combo Produces Robust Activity in Newly Diagnosed AML

By NewsCancerMarch 11, 20260

Combining mipletamig with venetoclax (Venclexta) and azacitidine (Vidaza) demonstrated robust clinical benefits among patients with newly diagnosed acute myeloid leukemia…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Scientists shut down cancer DNA repair to overcome drug resistance

The future is not always uniform: rethinking radiotherapy through spatial fractionation

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling

Browsing: Mipletamig

Mipletamig Regimen Yields Clinical Benefit in Frontline AML Trial

Mipletamig Combo Produces Robust Activity in Newly Diagnosed AML

Scientists shut down cancer DNA repair to overcome drug resistance

The future is not always uniform: rethinking radiotherapy through spatial fractionation

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

Scientists shut down cancer DNA repair to overcome drug resistance

The future is not always uniform: rethinking radiotherapy through spatial fractionation

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling

76 Real-World Safety of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Insights From US Community Oncology Practices

Latest Post

Scientists shut down cancer DNA repair to overcome drug resistance

The future is not always uniform: rethinking radiotherapy through spatial fractionation

CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor–stromal signaling

Subscribe to Updates

What's Hot

Browsing: Mipletamig